Intestinal microbiota and colorectal cancer: a new aspect of research

被引:2
|
作者
Koliarakis, Ioannis [1 ]
Psaroulaki, Anna [2 ]
Nikolouzakis, Taxiarchis Konstantinos [1 ]
Kokkinakis, Manolis [3 ]
Sgantzos, Markos N. [4 ]
Goulielmos, George [5 ]
Androutsopoulos, Vasilis P. [3 ]
Tsatsakis, Aristides [3 ]
Tsiaoussis, John [1 ]
机构
[1] Univ Crete, Lab Anat Histol Embryol, Med Sch, Iraklion 71110, Greece
[2] Univ Crete, Dept Clin Microbiol & Microbial Pathogenesis, Med Sch, Iraklion 71110, Greece
[3] Univ Crete, Lab Forens Sci & Toxicol, Med Sch, Iraklion 71409, Greece
[4] Univ Thessaly, Dept Anat, Fac Med, Larisa 41500, Greece
[5] Univ Crete, Sect Mol Pathol & Human Genet, Dept Internal Med, Med Sch, Iraklion 71003, Greece
来源
JOURNAL OF BUON | 2018年 / 23卷 / 05期
关键词
bowel preparation; chemotherapy; colorectal cancer; immunotherapy; intestinal microbiota; pathogenesis; ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; CHAIN FATTY-ACIDS; GUT MICROBIOTA; BETA-GLUCURONIDASE; COLON-CANCER; GASTROINTESTINAL MICROFLORA; CHECKPOINT-BLOCKADE; MOLECULAR-GENETICS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Colon holds a complex microbial community, which is crucial for maintaining homeostasis and regulating metabolic functions, supporting the intestinal barrier and controlling immune responses. Previous studies have supported a link between intestinal microbiota and colorectal cancer (CRC). Based on these findings, the present review analyzed the numerous interactions that occur between microbiota and CRC, starting from the role of intestinal microbiota in colonic homoeostasis. Intestinal microbiota is a cause of CRC and involves various mechanisms such as chronic inflammation, the production of genotoxins causing DNA impairment and/or the biosynthesis of toxic compounds. Moreover, basic metabolic factors such as short-chain fatty acids (SCFAs) and bile acids are included in CRC pathogenesis. Different pathogenic pathways have been reported among different CRC regions (proximal or distal). Variations in the microbial populations are reported between the CRC from these colonic sites, possibly reflecting the bacterial dysbiosis and biofilm distribution. Bowel preparation is essential prior to colonoscopy and surgery; there is, however, minor consensus on the effects of this procedure on intestinal microbiota, notably with regard to the long-term outcomes. With regard to the therapeutic strategy in CRC, the intestinal microbiota is further involved in the modulation of the host response to chemotherapeutic agents (5-fluorouracil and irinotecan) by the interference with drug efficacy and by adverse effects and associated toxicity. In addition, the newly emerged research on CRC immunotherapy reveals an important interplay between intestinal microbiota and the immune system, which includes the possibility of targeting microbiota for the enhancement of anticancer treatment. Additional studies will further clarify the interaction between microbiota and CRC, resulting in the development of alternative therapeutic strategies by manipulating microbiota composition.
引用
收藏
页码:1216 / 1234
页数:19
相关论文
共 50 条
  • [11] Intestinal microbiota, chronic inflammation, and colorectal cancer
    Park, Chan Hyuk
    Eun, Chang Soo
    Han, Dong Soo
    INTESTINAL RESEARCH, 2018, 16 (03) : 338 - 345
  • [12] The plasticity of the intestinal microbiota in colorectal cancer.
    Yang, Ye
    Gharaibeh, Raad
    Jobin, Christian
    CANCER RESEARCH, 2020, 80 (08) : 18 - 19
  • [13] Relationship between intestinal microbiota and colorectal cancer
    Cipe, Gokhan
    Idiz, Ufuk Oguz
    Firat, Deniz
    Bektasoglu, Huseyin
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (10) : 233 - 240
  • [14] Influence of intestinal microbiota on autophagy in colorectal cancer
    Nawfal, Rashad
    Noureldein, Mohamed
    Bitar, Sara
    Al Moussawi, Sarah
    Dia, Batoul
    El-Osta, Assam
    Khuri, Fadlo Raja
    Eid, Assaad Antoine
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [15] ALTERATIONS IN THE INTESTINAL MICROBIOTA PROMOTE COLORECTAL CANCER
    不详
    CANCER DISCOVERY, 2012, 2 (10) : 866 - 866
  • [16] Altered intestinal microbiota associated with colorectal cancer
    Hong Zhang
    Ying Chang
    Qingqing Zheng
    Rong Zhang
    Cheng Hu
    Weiping Jia
    Frontiers of Medicine, 2019, 13 : 461 - 470
  • [17] Altered intestinal microbiota associated with colorectal cancer
    Zhang, Hong
    Chang, Ying
    Zheng, Qingqing
    Zhang, Rong
    Hu, Cheng
    Jia, Weiping
    FRONTIERS OF MEDICINE, 2019, 13 (04) : 461 - 470
  • [18] Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in Colorectal Cancer
    Azimi, Maryam
    Shahbaz, Sanaz Keshavarz
    Mansourabadi, Amir Hossein
    Khosroshahi, Leila Mohamed
    Pourkalhor, Shahryar
    Rezakhani, Mehran
    Masoumi, Farimah
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2022, 183 (11) : 1147 - 1165
  • [19] Intestinal microbiota and colorectal cancer: changes in the intestinal microenvironment and their relation to the disease
    dos Reis, Sandra Aparecida
    da Conceicao, Lisiane Lopes
    Gouveia Peluzio, Maria do Carmo
    JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (10) : 1391 - 1407
  • [20] Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
    Ding, Chenbo
    Tang, Wendong
    Fan, Xiaobo
    Wu, Guoqiu
    ONCOTARGETS AND THERAPY, 2018, 11 : 4797 - 4810